Endocrine manifestations of diphenylhydantoin therapy
- 30 June 1974
- journal article
- Published by Elsevier in Metabolism
- Vol. 23 (6) , 515-524
- https://doi.org/10.1016/0026-0495(74)90079-1
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Diphenylhydantoin and an insulin-secreting islet adenomaArchives of internal medicine (1960), 1972
- Altered Calcium Metabolism in Epileptic Children on AnticonvulsantsBMJ, 1971
- Disturbance of Calcium Metabolism by Anticonvulsant DrugsBMJ, 1970
- Osteomalacia with Long-term Anticonvulsant Therapy in EpilepsyBMJ, 1970
- Lymphocytic thyroiditis possibly induced by diphenylhydantoinPublished by American Medical Association (AMA) ,1969
- Site of the Inhibiting Action of Diphenylhydantoin on the Release of Corticotrophin in Epileptic PatientsPharmacology, 1967
- Diphenylhydantoin intoxication associated with hyperglycemiaThe Journal of Pediatrics, 1966
- Induction of liver microsomal cortisol 6β-hydroxylase by diphenylhydantoin or phenobarbital: An explanation for the increased excretion of 6-hydroxycortisol in humans treated with these drugsLife Sciences, 1965
- Diphenylhydantoin and Brain-Levels of 5-HydroxytryptamineNature, 1956
- Hypertrichosis occurring in association with dilantintherapyThe Journal of Pediatrics, 1955